期刊文献+

铥激光与绿激光治疗80g以上高龄高危BPH的疗效比较 被引量:23

Greenlight photoselective vaporization prostatectomy versus thulium laser vaporesection of the prostate for aged high-risk BPH patients with the prostate heavier than 80g
下载PDF
导出
摘要 目的:比较经尿道选择性绿激光前列腺汽化术(PVP)与经尿道铥(2微米)激光前列腺汽化切除术(TmLRP)治疗80 g以上高龄高危良性前列腺增生(BPH)的疗效。方法:分别用PVP及TmLRP治疗80 g以上高龄BPH患者各82例、36例。比较两种术式的手术时间、费用、术中失血量,并发症及近期疗效等指标。结果:118例均安全度过围手术期,未出现严重并发症,未输血。TmLRP组的平均手术时间、术后膀胱冲洗时间及手术费用均明显少于PVP组(P<0.05)。两组术后国际前列腺症状评分(IPSS)、生活质量评分(QOL)、残余尿量(PVR)及最大尿流率(Qm ax)均明显改善(P(0.05),但两组间改善程度无明显差别(P(0.05)。结论:PVP与TmLRP治疗80 g以上高龄高危BPH安全有效,TmLRP在手术时间及费用方面优于PVP。 Objective: To compare the effects of greenlight photoselective vaporization prostatectomy(PVP) and thulium laser vaporesection of the prostate(TmLRP) in the treatment of aged high-risk BPH patients with the prostate weighing 80 g.Methods: We included in this study 118 high-risk BPH patients aged 62-96(mean 76) years with the prostate heavier than 80 g,82 treated by PVP and the other 36 by TmLRP.Then we compared the operation time,intraoperative bleeding,complications,short-term effectiveness,and surgical cost between the two groups.Results: All the patients tided over the perioperative period without blood transfusion and serious complications.The mean operation time,postoperative bladder irrigation time and surgical cost were significantly less in the TmLRP than in the PVP group(P0.05).Both the procedures remarkably improved the international prostatic symptom score(IPSS),quality of life(QOL),post void residual urine(PVR) and Qmax of the patients(P0.05),but with no significant differences between the two groups(P0.05).Conclusion: Both PVP and TmLRP are effective and safe for the treatment of aged high-risk BPH patients with the prostate heavier than 80 g,but the latter is superior for its shorter operation time and lower surgical cost.
出处 《中华男科学杂志》 CAS CSCD 北大核心 2011年第5期431-434,共4页 National Journal of Andrology
关键词 良性前列腺增生 高龄 高危 激光手术 benign prostatic hyperplasia aged high-risk patient laser surgery
  • 相关文献

参考文献9

  • 1Reich O, Gratzke C, Bachmann A, et al. Morbidity, mortality and early outcome of transurethral resection of the prostate: A prospective muhicenter evaluation of 10, 654 patients. J Urol, 2008, 180 ( 1 ) : 246-249.
  • 2Rassweiler J, Teber D, Kuntz R, et al. Complications of transurethral resection of the prostate (TURP) -- incidence, management and prevention. Eur Urol, 2006, 50 (5) : 969-979.
  • 3周文龙,沈周俊,楚晨龙,张志伟,王名伟,黄欣,刘定益,孙福康.85岁以上高危前列腺增生症患者行TUVP术的治疗分析(附104例报告)[J].中国男科学杂志,2009,23(5):39-42. 被引量:8
  • 4Kuntz RM. Current role of lasers in the treatment of benign prostatic hyperplasia(BPH). Eur Urol, 2006, 49(6) : 961-969.
  • 5Xia SJ, Zhuo J, Sun XW, et al. Thulium laser versus standard transurethral resection of the prostate: A randomized prospective trial. Eur Urol, 2008, 53(2) : 382-389.
  • 6Ruszat R, Wyler S, Forster T, et al. Safety and effectiveness of photoselective vaporization of the prostate (PVP) in patients on ongoing oral anticoagulation. Eur Urol, 2007, 51 (4): 1031- 1038.
  • 7Tugcu V, Tasci AI, Sahin S, et al. Comparison of photoselective vaporization of the prostate and transurethral resection of the prostate: A prospective nonrandomized bicenter trial with 2-year follow-up. J Endourol, 2008, 22(7) : 1519-1525.
  • 8Wendt-Nordahl G, Huckele S, Honeck P, et al. Systematic evaluation of a recently introduced 2-microm continuous-wave thulium laser for vaporesection of the prostate. J Endourol, 2008, 22 (5) : 1041-1045.
  • 9Seitz M. Editorial comment on: Thulium laser versus standard transurethral resection of the prostate: A randomized prospective trial. Eur Urol, 2008, 53 (2) : 390.

二级参考文献17

  • 1李建昌,张英杰,张会清,张竣,刘沛.经尿道前列腺电汽化切除术治疗前列腺增生症[J].中国内镜杂志,2004,10(12):30-31. 被引量:6
  • 2徐军,李会宁,陈斌.高危患者前列腺增生经尿道电切汽化治疗的临床探讨[J].中国内镜杂志,2006,12(5):493-494. 被引量:14
  • 3吴开俊.中国人前列腺增生症治疗现状与展望[J].中华泌尿外科杂志,1993,15:12-4.
  • 4AUA Practice Guidelines Committee.AUA guideline on management of benign prostatic hyperplasia (2003).Chapter 1:Diagnosis and treatment recommendations.J Urol 2003;170(2 Pt 1):530-547
  • 5Chung BH,Ko WJ,Kim SI,et al.Identification of baseline clinical factors that predict maintenance for medical treatment of BPH.Eur Urol 2002;1(suppl 1):106
  • 6de la Rosette JJ,Kortmann BB,Rossi C,et al.Long-term risk of re-treatment of patients using alpha-blockers for lower urinary tract symptoms.J Urol 2002;167(4):1734-1739
  • 7Wilt TJ.Treatment options for benign prostatic hyperplasia.BMJ 2002;324(7345):1047-1048
  • 8Mebust WK,Holtgrewe HL,Cocker AT,et al.Transurethral prostatectomy:immediate and postoperative complications.Cooperative study of 13 participating institutions evaluating 3,885 patients.J Urol,141:243-247,1989.J Urol 2002;167:5-9
  • 9Kupeli S,Soygur T,Yilmaz E,et al.Combined transurethral resection and vaporization of the prostate using newly designed electrode:a promising treatment alternative for benign prostatic liyperplasia.J Endourol 1999;13(3):225-228
  • 10Kupeli S,Baltaei S,Soygur T,et al.A prospective randomized study of transurethral resection of the prostate and transurethral vaporization of the prostate as a therapeutic alternative in the management of men with BPH.Eur Urol 1998;34(1):15-18

共引文献7

同被引文献194

引证文献23

二级引证文献131

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部